Federal enforcement action is one of the fastest ways that an otherwise profitable investment can go sour. A critical component of any healthcare acquisition is an assessment of the risk of adverse government action. Even small errors in that assessment can radically change the viability of a proposed deal.
In this interactive presentation, attorneys from Elliott Sauter will provide insight into some of the components of regulatory risk assessment: Structural analysis, evaluation of physician compensation, and the importance (and pitfalls) of fair market value analysis.
In addition to discussing these general principles, this expert panel will address several breaking trends in federal enforcement including the following:
The government’s increasing interest in the internal operations of private equity funds
Identifying the fine line between legitimate and criminal telemedicine arrangements in a post-Covid world
Understanding the rise (and potential fall) of healthcare “tech” companies